NanoSyrinx
PrivateLast Round
Series A
Sep 10, 2024
Total Funding Raised
$22.32M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NanoSyrinx is a biotechnology company that develops a synthetic biology platform for the targeted intracellular delivery of therapeutic proteins and peptides.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoSyrinx Comparables
Compare NanoSyrinx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyGenica | 83% | |
| Sapreme Technologies BV | 82% | |
| Xelcis Bio, Inc. | 80% |
NanoSyrinx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 10, 2024 | ||||
| Seed | Jul 14, 2021 | ||||
| Grant | Sep 30, 2020 | ||||
| Pre Seed | Sep 30, 2020 | ||||
| Grant | Jun 30, 2020 |
NanoSyrinx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Grant |
| BGF | Series A |
| Pioneer Group | Seed, Pre Seed |
| M Ventures | Seed, Pre Seed, Series A |
| Meltwind Advisory | Series A |
| IQ Capital | Seed, Series A |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 39% MoM, reaching 2.1K.
- Jun 19, 2026
Monthly visitors grew 202% MoM, reaching 1.5K.
NanoSyrinx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NanoSyrinx's valuation, stock price, and market status.
Is NanoSyrinx a public or private company?
NanoSyrinx is a private company.
What is the current stock price of NanoSyrinx?
NanoSyrinx is a private company with no public stock price. No recent secondary market data is available.
How much is NanoSyrinx worth (valuation)?
Valuation information for NanoSyrinx is not publicly available.
Can I buy NanoSyrinx stock?
NanoSyrinx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NanoSyrinx's last funding round?
NanoSyrinx's most recent funding round was Series A on September 10, 2024.
Who are the main investors in NanoSyrinx?
Key investors in NanoSyrinx include BGF, M Ventures, Octopus Ventures.
Will NanoSyrinx IPO soon?
No public IPO plans have been announced for NanoSyrinx.
How can I track NanoSyrinx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NanoSyrinx's secondary market activity and sign up for updates.